|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 3.5 Billion||USD 7.77 Billion||4.79%||2022|
Radiation Dose Management Market
The global radiation dose management market size was evaluated at $3.5 billion in 2022 and is slated to hit $7.77 billion by the end of 2030 with a CAGR of nearly 4.79% between 2023 and 2030.
Radiation is the energy that is emitted as a wave or particle that comes from a source and travels through materials or spaces. Additionally, radiation dose is the amount of radiation energy absorbed by the body which is measured in a number of ways. Furthermore, effective dose, equivalent dose and absorbed dose are some of the forms of radiation dose. Moreover, radiation dose management is a standard that provides healthcare experts with additional equipment to regulate and optimize the dose in CT scans and other modalities. This radiation dose management plays an important role in lowering the exposure of patients undergoing imaging procedures to these harmful radiation doses.
Growing demand for patient safety will drive the global market trends by 2030
Increasing necessity for patient protection & safety, stringent state & federal regulations, and obligations laid down for the healthcare providers are playing vital roles in the growth of this industry. Rise in the cases of chronic ailments and growing awareness about the side effects caused due to over-exposure to radiation dose can proliferate the expansion of the market across the globe. Increase in the deployment of radiology devices will prompt the global market demand. Large-scale demand for CT scans, imaging methods, and fluoroscopy can spike the market elevation across the globe. New product launches will further influence the expansion of the market globally over the coming years. For instance, in the first half of 2018, Sectra AB introduced Gadolinium Tracking for expanding its radiation dose monitoring solution portfolio.
Lack of fund allocation for radiation dose management activities will impede the global industry surge over 2023-2030
Insufficient funding in radiation dose management and lack of standard protocols are hindering the growth of the global radiation dose management industry across the globe.
Growing focus of industry players on use of nuclear medicine & radiology to open new growth opportunities for the global market
Surge in the focus of firms on practicing interventional radiology & nuclear medicine will offer new growth avenues for the radiation dose management market globally over the upcoming years.
Lack of standard protocols over the use of radiation doses in various developing countries can obstruct the global industry expansion
Lack of radiation dose benchmarking for radiology methods by governments in emerging economies can pose a huge challenge for the global radiation dose management industry expansion in the years ahead.
The global radiation dose management market is sectored into product, application, and region.
In modality terms, the global radiation dose management market is segregated into computed tomography, fluoroscopy & interventional imaging, radiography & mammography, and nuclear medicine segments. Furthermore, the computed tomography segment, which accrued nearly 60% of the global market revenue share in 2022, is projected to record the fastest CAGR in the years ahead. The growth of the segment in the assessment timeframe can be subject to an increase in the number of CT examinations across the globe.
Based on the end-user, the global radiation dose management industry is sectored into ambulatory care settings, hospitals, and other end-users segments. Moreover, the hospitals segment, which garnered a huge chunk of the global industry revenue share in 2022, is projected to lead the global industry over the analysis timespan. The segmental expansion over the assessment timeframe can be owing to rising awareness about the benefits of early diagnosis of ailment and technological advancements in imaging modalities.
|Report Attributes||Report Details|
|Report Name||Radiation Dose Management Market|
|Market Size in 2022||USD 3.5 Billion|
|Market Forecast in 2030||USD 7.77 Billion|
|Growth Rate||CAGR of 4.79%|
|Number of Pages||221|
|Key Companies Covered||Sectra Medical Systems, Novarad Corporation, PACSHealth LLC, Bayer AG, Fujifilm Holdings Corporation, and others.|
|Segments Covered||By Modality, By End-User, and By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North America is anticipated to maintain global market domination over the expected timeline
North America, which contributed about half of the global radiation dose management market revenue in 2022, is likely to retain its market dominance over the projected timespan. Furthermore, the regional market growth can be due to strict laws as well as accreditation needs related to optimizing and reporting radiation doses along with large-scale acceptance of HCIT systems and string laws associated with patient safety.
Asia-Pacific radiation dose management industry is set to register the fastest CAGR in the upcoming years can be due to the presence of strong healthcare systems in the region. Moreover, the availability of advanced radiation dose-managing devices in countries such as India, South Korea, China, Japan, and Taiwan will further proliferate the growth of the industry in APAC. Moreover, the presence of key players in the region will further steer the regional industry trends.
The global radiation dose management market profiles key players such as:
Radiation dose management is a standard that provides healthcare experts with additional equipment to regulate and optimize the dose in CT scans and other modalities.
The global radiation dose management market growth can be owing to a rise in the cases of chronic ailments and growing awareness about the side effects caused due to over-exposure to radiation dose.
According to a study, the global radiation dose management industry size was $3.5 billion in 2022 and is projected to reach $7.77 billion by the end of 2030.
The global radiation dose management market is anticipated to record a CAGR of nearly 4.79% from 2023 to 2030.
The Asia-Pacific radiation dose management industry is set to register the highest CAGR over the forecasting timeline owing to the presence of strong healthcare systems in the region. Moreover, the availability of advanced radiation dose-managing devices in countries such as India, South Korea, China, Japan, and Taiwan will further proliferate the growth of the industry in APAC.
The global radiation dose management market is led by players such as Sectra Medical Systems, Novarad Corporation, PACSHealth LLC, Bayer AG, and Fujifilm Holdings Corporation.
The radiation dose management market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.